|
Market Cap (1-Jul) $71,840,344 (1,153rd) |
Close (30-Jun) $0.025 |
Volume (30-Jun) 981,823 |
Shortsold (10-Jun) 33,792 (0.00%) (569th) |
|
52w High $0.060 |
52w Low $0.024 |
P/E - |
EPS -0.01 |
PCK released this announcement to the ASX on 28 April 2023, 15:25. The announcement is marked as price sensitive, and is 13 page(s) in length and 1.4MB in size.
You can view all announcements from PCK and see how they appear on a price chart on the announcements page.
At the date of this announcement, PCK was 0.001% short sold according to ASIC data. It was ranked the 627th most shorted stock on the ASX. It is now ranked as the 569th most shorted stock on the ASX with 0.002% of total shares short sold as of the latest reported data (10 June 2025).
| Other Recent Announcements from PCK | |
|---|---|
| Ethos Laboratories Distribution Agreement | 15 June 2023, 10:52 |
| Investor Presentation Webinar | 2 May 2023, 8:31 |
| Quarterly Investor Webinar - Tuesday 2 May | 28 April 2023, 16:30 |
| Quarterly Update and Appendix 4C | 28 April 2023, 15:25 |
| PainChek to Present at NWR Virtual Healthcare Conference | 15 March 2023, 17:10 |
| Change of Director's Interest Notices x 5 | 9 March 2023, 12:38 |
| Notification of cessation of securities - PCK | 9 March 2023, 12:12 |
You must be logged in to post a reply.
PainChek 